DK374289A - Indazol-3-carboxylsyrederivater, deres fremstilling og anvendelse - Google Patents
Indazol-3-carboxylsyrederivater, deres fremstilling og anvendelse Download PDFInfo
- Publication number
- DK374289A DK374289A DK374289A DK374289A DK374289A DK 374289 A DK374289 A DK 374289A DK 374289 A DK374289 A DK 374289A DK 374289 A DK374289 A DK 374289A DK 374289 A DK374289 A DK 374289A
- Authority
- DK
- Denmark
- Prior art keywords
- indazol
- preparation
- carboxylic acid
- acid derivatives
- derivatives
- Prior art date
Links
- BHXVYTQDWMQVBI-UHFFFAOYSA-N 1h-indazole-3-carboxylic acid Chemical class C1=CC=C2C(C(=O)O)=NNC2=C1 BHXVYTQDWMQVBI-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/08—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP19190488 | 1988-07-29 | ||
| JP32298688 | 1988-12-20 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK374289D0 DK374289D0 (da) | 1989-07-28 |
| DK374289A true DK374289A (da) | 1990-01-30 |
Family
ID=26506977
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK374289A DK374289A (da) | 1988-07-29 | 1989-07-28 | Indazol-3-carboxylsyrederivater, deres fremstilling og anvendelse |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5017573A (fr) |
| EP (1) | EP0358903A3 (fr) |
| JP (2) | JPH0655738B2 (fr) |
| KR (1) | KR910002839A (fr) |
| AU (1) | AU621642B2 (fr) |
| DK (1) | DK374289A (fr) |
| FI (1) | FI893592A7 (fr) |
| HU (1) | HU204816B (fr) |
| NO (1) | NO173652C (fr) |
| NZ (1) | NZ230068A (fr) |
| PT (1) | PT91287B (fr) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9214184D0 (en) * | 1992-07-03 | 1992-08-12 | Smithkline Beecham Plc | Pharmaceuticals |
| US5989586A (en) * | 1992-10-05 | 1999-11-23 | Cygnus, Inc. | Two-phase matrix for sustained release drug delivery device |
| US5654320A (en) * | 1995-03-16 | 1997-08-05 | Eli Lilly And Company | Indazolecarboxamides |
| IL117438A (en) * | 1995-03-16 | 2001-12-23 | Lilly Co Eli | Indazolecarboxamides, their preparation and pharmaceutical compositions containing them |
| EP0829474B1 (fr) * | 1995-05-31 | 2003-04-09 | Nisshin Seifun Group Inc. | Derives de l'indazole a groupe amino monocyclique |
| DK0855397T3 (da) * | 1995-07-28 | 2001-06-25 | Dainippon Pharmaceutical Co | (R)-5-brom-N-(ethyl-4-methylhexahydro-1H-1,4-diazepin-6-yl)-2-methoxy-6-methylamino-3-pyridincarboxamid, fremgangsmåde til dets fremstilling og medicinsk præparat indeholdende denne forbindelse |
| US6046185A (en) * | 1996-07-11 | 2000-04-04 | Inflazyme Pharmaceuticals Ltd. | 6,7-oxygenated steroids and uses related thereto |
| US6069152A (en) * | 1997-10-07 | 2000-05-30 | Eli Lilly And Company | 5-HT4 agonists and antagonists |
| US5914405A (en) * | 1997-10-07 | 1999-06-22 | Eli Lilly And Company | Process for preparing 3-substituted indazoles |
| GB9721139D0 (en) | 1997-10-07 | 1997-12-03 | Glaxo Group Ltd | Medicaments |
| DE10041478A1 (de) * | 2000-08-24 | 2002-03-14 | Sanol Arznei Schwarz Gmbh | Neue pharmazeutische Zusammensetzung |
| CA2464333C (fr) * | 2001-10-26 | 2011-07-26 | University Of Connecticut | Heteroindanes: nouvelle classe de ligands cannabimimetiques efficaces |
| TW200533348A (en) * | 2004-02-18 | 2005-10-16 | Theravance Inc | Indazole-carboxamide compounds as 5-ht4 receptor agonists |
| US8309575B2 (en) | 2004-04-07 | 2012-11-13 | Theravance, Inc. | Quinolinone-carboxamide compounds as 5-HT4 receptor agonists |
| US7728006B2 (en) * | 2004-04-07 | 2010-06-01 | Theravance, Inc. | Quinolinone-carboxamide compounds as 5-HT4 receptor agonists |
| TWI351282B (en) | 2004-04-07 | 2011-11-01 | Theravance Inc | Quinolinone-carboxamide compounds as 5-ht4 recepto |
| TW200621237A (en) | 2004-11-01 | 2006-07-01 | Wyeth Corp | [(1-h-indazol-3-yl)methyl]phenols and (hydroxyphenyl)(1h-indazol-3-yl)methanones |
| US7399862B2 (en) * | 2004-11-05 | 2008-07-15 | Theravance, Inc. | 5-HT4 receptor agonist compounds |
| WO2006052889A2 (fr) * | 2004-11-05 | 2006-05-18 | Theravance, Inc. | Composes de quinolinone-carboxamide |
| CA2588037A1 (fr) * | 2004-12-22 | 2006-06-29 | Theravance, Inc. | Composes d'indazole-carboxamide |
| CN101163701A (zh) * | 2005-03-02 | 2008-04-16 | 施万制药 | 作为5-ht4受体激动剂的喹啉酮化合物 |
| CN102458400B (zh) | 2009-05-20 | 2014-10-08 | 国立健康与医学研究所 | 用于治疗病灶性前庭功能障碍的血清素5-ht3受体拮抗剂 |
| EP2253316B1 (fr) | 2009-05-20 | 2013-08-14 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Antagonistes du récepteur 5-HT3 de la sérotonine pour une utilisation dans le traitement ou la prévention d'une pathologie de l'oreille interne avec déficits vestibulaires |
| JOP20130213B1 (ar) | 2012-07-17 | 2021-08-17 | Takeda Pharmaceuticals Co | معارضات لمستقبلht3-5 |
| GB201511382D0 (en) | 2015-06-29 | 2015-08-12 | Imp Innovations Ltd | Novel compounds and their use in therapy |
| JP2025530213A (ja) | 2022-09-09 | 2025-09-11 | ミリックス ファーマ リミテッド | Ｎｍｔ阻害剤を含む抗体薬物コンジュゲート及びその使用 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1069122A (fr) * | 1975-11-11 | 1980-01-01 | W.R. Grace And Co. | Preparation de hexahydropyrimidine-1, 3-diacetate de di (metal alcalin) et de 5-hydroxyhexahydropyrimidine-1, 3-diacetate de di (metal alcalin) |
| JPS5925785B2 (ja) * | 1976-01-01 | 1984-06-21 | 山之内製薬株式会社 | 新規なカルボン酸アミド誘導体 |
| US4207327A (en) * | 1977-08-19 | 1980-06-10 | A. H. Robins Company, Inc. | N-(4-Pyrazolidinyl)benzamides and their amino precursors |
| EP0049779B1 (fr) * | 1980-09-18 | 1984-10-31 | Asahi Kasei Kogyo Kabushiki Kaisha | Dérivés de 3-aminoindazoles et leur procédé de préparation |
| CA1220141A (fr) * | 1981-06-13 | 1987-04-07 | John R. Fozard | Traitement de la migraine avec des derives de benzoate de tropyle |
| FI74707C (fi) * | 1982-06-29 | 1988-03-10 | Sandoz Ag | Foerfarande foer framstaellning av terapeutiskt anvaendbara alkylenoeverbryggade piperidylestrar eller -amider av bicykliska karboxylsyror. |
| JPS60123485A (ja) * | 1983-12-08 | 1985-07-02 | Yoshitomi Pharmaceut Ind Ltd | インド−ル−３−カルボキサミド誘導体 |
| DE3677609D1 (de) * | 1985-01-23 | 1991-04-04 | Hoechst Roussel Pharma | 3-piperidinyl- 1h-indazole, verfahren zu deren herstellung und deren anwendung als arzneimittel. |
| GB8623142D0 (en) * | 1986-09-26 | 1986-10-29 | Beecham Group Plc | Compounds |
| DE3687080T2 (de) * | 1985-04-27 | 1993-03-25 | Beecham Group Plc | Azabicyclononyl-indazol-carboxamid mit 5-ht-antagonistischer wirkung. |
| GB8520616D0 (en) * | 1985-08-16 | 1985-09-25 | Beecham Group Plc | Compounds |
| GB8527052D0 (en) * | 1985-11-02 | 1985-12-04 | Beecham Group Plc | Compounds |
| ES2053451T3 (es) * | 1986-01-07 | 1994-08-01 | Beecham Group Plc | Un procedimiento para la preparacion de un compuesto que tiene propiedades farmacologicas utiles. |
| EP0235878A3 (fr) * | 1986-01-16 | 1989-06-14 | Beecham Group Plc | Nouveaux composés |
| DE3822792C2 (de) * | 1987-07-11 | 1997-11-27 | Sandoz Ag | Neue Verwendung von 5HT¶3¶-Antagonisten |
| EP0410509A1 (fr) * | 1989-07-25 | 1991-01-30 | Duphar International Research B.V | Indazole-1H-carboxamides-3 substitués |
| US4954503A (en) * | 1989-09-11 | 1990-09-04 | Hoechst-Roussel Pharmaceuticals, Inc. | 3-(1-substituted-4-piperazinyl)-1H-indazoles |
-
1989
- 1989-07-25 US US07/384,766 patent/US5017573A/en not_active Expired - Fee Related
- 1989-07-25 NZ NZ230068A patent/NZ230068A/en unknown
- 1989-07-26 PT PT91287A patent/PT91287B/pt not_active IP Right Cessation
- 1989-07-26 EP EP19890113776 patent/EP0358903A3/fr not_active Withdrawn
- 1989-07-27 HU HU893824A patent/HU204816B/hu not_active IP Right Cessation
- 1989-07-27 JP JP1196351A patent/JPH0655738B2/ja not_active Expired - Lifetime
- 1989-07-27 FI FI893592A patent/FI893592A7/fi not_active Application Discontinuation
- 1989-07-27 KR KR1019890010658A patent/KR910002839A/ko not_active Ceased
- 1989-07-28 NO NO893078A patent/NO173652C/no unknown
- 1989-07-28 DK DK374289A patent/DK374289A/da not_active Application Discontinuation
- 1989-07-28 AU AU39103/89A patent/AU621642B2/en not_active Ceased
-
1992
- 1992-01-31 JP JP4046294A patent/JP2898139B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0358903A3 (fr) | 1992-03-04 |
| US5017573A (en) | 1991-05-21 |
| JPH0592959A (ja) | 1993-04-16 |
| AU3910389A (en) | 1990-02-01 |
| AU621642B2 (en) | 1992-03-19 |
| PT91287A (pt) | 1990-02-08 |
| NO893078D0 (no) | 1989-07-28 |
| NO173652B (no) | 1993-10-04 |
| EP0358903A2 (fr) | 1990-03-21 |
| JPH02256670A (ja) | 1990-10-17 |
| PT91287B (pt) | 1995-03-01 |
| FI893592A0 (fi) | 1989-07-27 |
| KR910002839A (ko) | 1991-02-26 |
| NO173652C (no) | 1994-01-12 |
| HUT52093A (en) | 1990-06-28 |
| FI893592A7 (fi) | 1990-01-30 |
| NZ230068A (en) | 1991-07-26 |
| NO893078L (no) | 1990-01-30 |
| HU204816B (en) | 1992-02-28 |
| JPH0655738B2 (ja) | 1994-07-27 |
| DK374289D0 (da) | 1989-07-28 |
| JP2898139B2 (ja) | 1999-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK374289A (da) | Indazol-3-carboxylsyrederivater, deres fremstilling og anvendelse | |
| DK609489A (da) | Imidazolderivater, deres fremstilling og anvendelse | |
| DK605489A (da) | Beta-amino-boronsyre-derivater, deres fremstilling og anvendelse | |
| NO892745D0 (no) | Aminoalkylaminokarbonylaminodiolaminosyrederivater og fremgangsmaate for deres fremstilling. | |
| DK399789D0 (da) | Annellerede tetrahydropyridineddikesyrederivater, deres fremstilling og anvendelse | |
| DK595388D0 (da) | Benzopyranderivater, deres fremstilling og anvendelse | |
| DK388989A (da) | Acylcyanoguanidiner, deres fremstilling og anvendelse | |
| DK193088A (da) | 2-acylpyrrolidin-derivater, deres fremstilling og anvendelse | |
| DK435289A (da) | Piperazindioner, deres fremstilling og anvendelse | |
| DK633287A (da) | Carbamoylimidazo-derivater, deres fremstilling og anvendelse | |
| DK278188D0 (da) | Thiazolidin-4-on-derivater, deres fremstilling og anvendelse | |
| DK235787A (da) | Tripeptidderivater, deres fremstilling og anvendelse | |
| DK225089D0 (da) | 2-adamantyl-4-isothiazolin-3-oner, deres fremstilling og anvendelse | |
| DK189488A (da) | Imidazothiadiazinderivater, deres fremstilling og anvendelse | |
| DK469389D0 (da) | Piperidinyl-imidazol-derivater, deres fremstilling og anvendelse | |
| DK213387D0 (da) | Benzothiazinon-derivater, deres fremstilling og anvendelse | |
| DK212687A (da) | Benzothiazinon-derivater, deres fremstilling og anvendelse | |
| DK548586A (da) | Thienylsulfonylguanidin-derivater, deres fremstilling og anvendelse | |
| DK223288A (da) | Benzensulfornamid-derivater, deres fremstilling og anvendelse | |
| DK610787A (da) | Substituerede thienoimidazoltoluidin-derivater, deres fremstilling og anvendelse | |
| DK412188D0 (da) | Benzothiazinon-derivater, deres fremstilling og anvendelse | |
| DK361388A (da) | Cephemderivater, deres fremstilling og anvendelse | |
| DK613888D0 (da) | Acyllabdan-derivater, deres fremstilling og anvendelse | |
| DK668788A (da) | Labdanderivater, deres fremstilling og anvendelse | |
| DK668888D0 (da) | Labdan-derivater, deres fremstilling og anvendelse |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHB | Application shelved due to non-payment |